Ripple kopen? Dit zijn de mogelijkheden

Pixium Vision SA Aandeel

0,53EUR 0,00EUR -0,56%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Pixium Vision SA - Profiel

Pixium Vision SA is a bioelectronics company, which engages in the development of retinal implant systems specializing in sensory neuromodulation. Its products include Intelligent Retinal Implant Systems and PRIMA system. The IRIS treats patients who have lost their sight through degenerative conditions of the eye such as retinitis pigmentosa, other retinal dystrophies or age-related macular degeneration. The PRIMA system is designed to enable physiological signal processing, while simplifying the surgical procedure. The company was founded on Jose-Alain Sahel, Bernard Gilly, Serge Picaud, Christoph Posch, Philippe Bergonzo and Lionel Rousseau in December, 2011 and is headquartered in Paris, France.

Aandeelhouder

Eigenaar in %
Freefloat0,49
Sofinnova Partners SAS0,19
Abingworth LLP0,10
BPIFrance Investissement SAS0,10
Bpifrance Participations SA /PRIVATE EQUITY/0,07
Hsbc Micro Caps Eur0,01
0,01
Bernard Jacques Alex Gilly, PhD0,01
Actys 10,01
Arc Skyliner0,00
Etoile Sant? Europe0,00
Pixium Vision SA0,00
Actys 30,00
Seventure Partners SA0,00

Adres

74, rue du Faubourg Saint-Antoine, 75012 Paris
Postbus:
Telefoon: 33.1.76.21.47.68
Fax: 33.1.43.42.05.26
Internet: http://www.pixium-vision.com

Management

Bernard Jacques Alex Gilly
Chairman
Lloyd Marc Diamond
Chief Executive Officer
Didier Laurens
Chief Financial Officer
Guillaume Buc
Chief Technology Officer
Gérard Hascoët
Director
Marie Meynadier
Director
Olivia Le Proux de la Rivière
Director
Karine Chevrie
Director-Regulatory Affairs & Quality
Robert J. W. ten Hoedt
Independent Director

Invoer toevoegen